https://www.selleckchem.com/products/AZD0530.html
001) compared to the untreated cells. IL-9 secretion (p less then 0.001) and PU.1 gene expression levels (p less then 0.05) were slightly higher in asthmatic patients' PBMCs before treatment but hormone therapy did not affect the level of them. Although the untreated asthmatic PBMCs produced a lower amount of IFN-γ compared to HCs (p less then 0.01), hormone treatment did not affect the levels of IFN-γ secretion in patient groups. Moreover, we did not observe any significant changes in IL-10 and TGF-β secretion in the supernatant